Courses & Units

Medicinal Chemistry and Drug Development CSA225

Introduction

This unit covers fundamental features and current methods involved in the medicinal chemistry and drug development process. The unit emphasises on lead identification, lead optimisation and the introduction of new drugs into clinical practice. It deals with specific case studies that examine real life drug discovery projects and how a range of drug design techniques are applied in each case. Novel drug delivery systems (e.g. recombinant DNA technology, liposome, gene therapy, monoclonal antibodies etc.) are also covered in detail. In addition, the study of chemical structure as a determinant of both the physicochemical properties and biological activity (including metabolic fate) of drug molecules of both synthetic and natural origin are also covered in detail.

Summary

Unit name Medicinal Chemistry and Drug Development
Unit code CSA225
Credit points 12.5
College/School College of Health and Medicine
School of Pharmacy and Pharmacology
Discipline Pharmacy
Coordinator Doctor Rahul Patel
Available as an elective? No
Delivered By University of Tasmania
Level Intermediate

Availability

Location Study period Attendance options Available to
Hobart Semester 1 On-Campus International Domestic
Hobart Semester 2 On-Campus International Domestic

Key

On-campus
Off-Campus
International students
Domestic students

Key Dates

Study Period Start date Census date WW date End date
Semester 2 11/7/2022 9/8/2022 29/8/2022 16/10/2022
Semester 1 21/2/2022 22/3/2022 11/4/2022 29/5/2022

* The Final WW Date is the final date from which you can withdraw from the unit without academic penalty, however you will still incur a financial liability (refer to How do I withdraw from a unit? for more information).

Unit census dates currently displaying for 2022 are indicative and subject to change. Finalised census dates for 2022 will be available from the 1st October 2021. Note census date cutoff is 11.59pm AEST (AEDT during October to March).

About Census Dates

Learning Outcomes

  • Demonstrate an understanding of fundamental and scientific principles of drug discovery and drug development in the context of the clinical application of medicines.
  • Describe the available options and demonstrate appropriateness of various drug delivery methods and technology.
  • Describe basic / advanced biological pathways of metabolism and excretion of drugs, and factors that influence these processes in determining the biological activity of drugs.

Fee Information

Field of Education Commencing Student Contribution 1,3 Grandfathered Student Contribution 1,3 Approved Pathway Course Student Contribution 2,3 Domestic Full Fee 4
019907 $1,002.00 $1,002.00 not applicable $2,354.00

1 Please refer to more information on student contribution amounts.
2 Please refer to more information on eligibility and Approved Pathway courses.
3 Please refer to more information on eligibility for HECS-HELP.
4 Please refer to more information on eligibility for FEE-HELP.

If you have any questions in relation to the fees, please contact UConnect or more information is available on StudyAssist.

Please note: international students should refer to What is an indicative Fee? to get an indicative course cost.

Requisites

Prerequisites

KRA113 AND KRA114

Teaching

Teaching Pattern

Self-directed online learning activities (3-hours weekly) and workshops (2-hours weekly)

AssessmentExamination 1 (30%)|Examination 2 (35%)|Examination 3 (35%)
TimetableView the lecture timetable | View the full unit timetable

Textbooks

Required

Required readings will be listed in the unit outline prior to the start of classes.

LinksBooktopia textbook finder

The University reserves the right to amend or remove courses and unit availabilities, as appropriate.